secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75389 grounded facts newest July 14, 2026, 4:53 PM ET RSS · JSON

Showing 4601–4650 of 18416

Appointed

Marcos Gabriel

Executive Vice President and Chief Financial Officer
MKC · MCCORMICK & CO INC
Effective
2024-12-01
Filed
June 26, 2024, 7:59 PM ET
On June 25, 2024, the Board of Directors (the “Board”) of McCormick & Company, Incorporated (“McCormick”) appointed Marcos Gabriel as Executive Vice President and Chief Financial Officer of McCormick effective December 1, 2024.
Appointed

Karen Parkhill

Chief Financial Officer
HPQ · HP INC
Effective
2024-08-05
Filed
June 26, 2024, 7:59 PM ET
On June 25, 2024, HP appointed Karen Parkhill as its Chief Financial Officer, effective August 5, 2024
Role change (interim)

Timothy Brown

interim Chief Financial Officer
HPQ · HP INC
Effective
2024-08-05
Successor
Karen Parkhill
Filed
June 26, 2024, 7:59 PM ET
Timothy Brown will step down as interim Chief Financial Officer of HP Inc. (“HP”) effective upon HP’s appointment of a new Chief Financial Officer on August 5, 2024, as disclosed below.
Departed

Winthrop Watson

President and Chief Executive Officer
Federal Home Loan Bank of Pittsburgh
Effective
2024-12-31
Successor
David G. Paulson
Filed
June 26, 2024, 7:59 PM ET
On June 24, 2024, Winthrop Watson, President and Chief Executive Officer (CEO) of the Federal Home Loan Bank of Pittsburgh (Bank), notified the Bank’s Board of Directors (Board) that he intends to retire from the Bank, effective December 31, 2024.
Appointed

David G. Paulson

President and Chief Executive Officer
Federal Home Loan Bank of Pittsburgh
Effective
2024-12-31
Filed
June 26, 2024, 7:59 PM ET
The Board has named David G. Paulson as President and CEO, effective upon Mr. Watson’s retirement.
Appointed

Edward Dulac

Executive Vice President and Chief Financial Officer
NTLA · Intellia Therapeutics, Inc.
Effective
2024-07-22
Filed
June 26, 2024, 7:59 PM ET
the Company announced the appointment, effective July 22, 2024 (“Start Date”), of Edward Dulac to serve as Executive Vice President and Chief Financial Officer (“CFO”), treasurer and principal financial officer of the Company.
Departed

Glenn Goddard

Chief Financial Officer
NTLA · Intellia Therapeutics, Inc.
Effective
2024-06-30
Successor
Edward Dulac
Filed
June 26, 2024, 7:59 PM ET
the Company also announced that Glenn Goddard, the Company’s current CFO, will step down effective June 30, 2024.
Departed

Scott W. Wine

Chief Executive Officer
CNH · CNH Industrial N.V.
Effective
2024-07-01
Successor
Gerrit Marx
Filed
June 26, 2024, 7:59 PM ET
the Company’s current Chief Executive Officer, Scott W. Wine, will continue in such role until July 1, 2024.
Appointed

Gerrit Marx

Chief Executive Officer
CNH · CNH Industrial N.V.
Effective
2024-07-01
Filed
June 26, 2024, 7:59 PM ET
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departed

William J. Fehrman

President and Chief Executive Officer
CTRI · Centuri Holdings, Inc.
Effective
2024-07-31
Successor
Paul J. Caudill
Filed
June 26, 2024, 7:59 PM ET
On June 21, 2024, William J. Fehrman, the President and Chief Executive Officer of Centuri Holdings, Inc. (the “Company”), informed the Company’s Board of Directors (the “Board”) of his decision to resign as President and Chief Executive Officer, effective July 31, 2024.
Appointed (interim)

Paul J. Caudill

Chief Executive Officer
CTRI · Centuri Holdings, Inc.
Effective
2024-07-31
Filed
June 26, 2024, 7:59 PM ET
Until a permanent successor is identified, the Company has appointed Paul J. Caudill to serve as the Company’s interim Chief Executive Officer, effective July 31, 2024.
Departed

Dr. Jordan Plews

chief executive officer
ELAB · PMGC Holdings Inc.
Effective
2024-06-21
Successor
Graydon Bensler
Filed
June 26, 2024, 7:59 PM ET
Dr. Jordan Plews, notified the board of directors of the Company (the “Board”) of his intention to resign as chief executive officer of the Company , effective on the close of business on June 21, 2024.
Appointed

Graydon Bensler

non-employee Chief Executive Officer
ELAB · PMGC Holdings Inc.
Effective
2024-06-21
Filed
June 26, 2024, 7:59 PM ET
the Board appointed our current chief financial officer and director, Mr. Graydon Bensler, as non-employee Chief Executive Officer of the Company.
Departed

Richard Eisenstadt

Chief Financial Officer
ALT · Altimmune, Inc.
Effective
2024-06-24
Successor
Andrew Shutterly
Filed
June 26, 2024, 7:59 PM ET
following the unexpected death of Richard Eisenstadt, the Company’s Chief Financial Officer.
Appointed (interim)

Andrew Shutterly

acting Chief Financial Officer
ALT · Altimmune, Inc.
Effective
2024-06-25
Filed
June 26, 2024, 7:59 PM ET
appointed Andrew Shutterly as acting Chief Financial Officer
Departed

Jennings 'Jay' Walker

Executive Vice President and Chief Financial Officer
CBNK · Capital Bancorp Inc
Effective
2024-08-01
Filed
June 26, 2024, 7:59 PM ET
On June 24, 2024, Jennings "Jay" Walker, Executive Vice President and Chief Financial Officer of Capital Bancorp, Inc. (the "Company") and its banking subsidiary, Capital Bank, N.A. (the "Bank"), informed the Company and the Bank of his decision to resign, effective August 1, 2024.
Departed

Adrienne Anderson

Chief Financial Officer
WBSR · Webstar Technology Group Inc.
Effective
2024-06-26
Filed
June 26, 2024, 7:59 PM ET
the existing officers and directors of the Company, Mr. James Owens, Mr. Michael Hendrickson, Mr. Sanford Simon, Mr. Don Roberts and Ms. Adrienne Anderson have either resigned or been voted out of their positions.
Appointed (interim)

Adrienne Anderson

Chief Financial Officer (transitional)
WBSR · Webstar Technology Group Inc.
Effective
2024-06-26
Filed
June 26, 2024, 7:59 PM ET
CFO – Ms. Adrienne Anderson (transitional)
Appointed

Ricardo Haynes

Chairman/CEO
WBSR · Webstar Technology Group Inc.
Effective
2024-06-26
Filed
June 26, 2024, 7:59 PM ET
Chairman/CEO - Mr. Ricardo Haynes
Appointed (interim)

Gary Corona

interim Chief Financial Officer
MDT · Medtronic plc
Effective
2024-08-02
Filed
June 26, 2024, 7:59 PM ET
On June 26, 2024, the Company announced that Gary Corona, currently Senior Vice President, Global Financial Planning and Analysis, has been appointed to serve as interim Chief Financial Officer (Interim CFO) of the Company, effective upon Ms. Parkhill’s departure.
Departed

Karen L. Parkhill

Executive Vice President and Chief Financial Officer
MDT · Medtronic plc
Effective
2024-08-02
Successor
Gary Corona
Filed
June 26, 2024, 7:59 PM ET
On June 21, 2024, Karen L. Parkhill, Executive Vice President and Chief Financial Officer of Medtronic plc (Company), notified the Company of her decision to resign from the Company, effective August 2, 2024.
Departed

Ken Rizvi

Chief Financial Officer
PENG · Penguin Solutions, Inc.
Effective
2024-06-26
Successor
Nathan Olmstead
Filed
June 26, 2024, 7:59 PM ET
the Company and Ken Rizvi (who previously served as the Company’s CFO and who had resigned effective as of June 30, 2024, as reported by the Company in its Current Report on Form 8-K filed on May 14, 2024) mutually agreed that Mr. Rizvi’s resignation would instead take effect immediately prior to the effectiveness of Mr. Olmstead’s appointment.
Appointed

Nathan Olmstead

Senior Vice President and Chief Financial Officer
PENG · Penguin Solutions, Inc.
Effective
2024-06-26
Filed
June 26, 2024, 7:59 PM ET
On June 25, 2024, the Board of Directors (the “Board”) of SMART Global Holdings, Inc. (the “Company”) appointed Nathan Olmstead as the Company’s Senior Vice President and Chief Financial Officer (“CFO”), effective as of June 26, 2024 (the “Start Date”).
Appointed

Kevin Nihill

Chief Financial Officer and Treasurer
RBKB · Rhinebeck Bancorp, Inc.
Effective
2024-07-08
Filed
June 25, 2024, 7:59 PM ET
appointed Kevin Nihill, CFA, as Chief Financial Officer and Treasurer of the Company, Rhinebeck Bancorp, MHC and the Bank, effective July 8, 2024
Departed

Michael J. McDermott

Chief Financial Officer and Treasurer
RBKB · Rhinebeck Bancorp, Inc.
Effective
2024-05-31
Successor
Kevin Nihill
Filed
June 25, 2024, 7:59 PM ET
Mr. Nihill succeeds Michael J. McDermott who retired as Chief Financial Officer and Treasurer of the Company, Rhinebeck Bancorp, MHC and the Bank, effective May 31, 2024
Appointed

Jon DeGaynor

President and Chief Executive Officer
MEI · METHODE ELECTRONICS INC
Effective
2024-07-15
Filed
June 25, 2024, 7:59 PM ET
On June 25, 2024, Methode Electronics, Inc. (the “Company” or “Methode”) announced the appointment of Jon DeGaynor as the Company’s new President and Chief Executive Officer, starting July 15, 2024.
Departed (interim)

Kevin Nystrom

Interim Chief Executive Officer
MEI · METHODE ELECTRONICS INC
Effective
2024-07-15
Successor
Jon DeGaynor
Filed
June 25, 2024, 7:59 PM ET
Mr. DeGaynor will replace Kevin Nystrom, who has served as Interim Chief Executive Officer since May 7, 2024.
Appointed

Dr. Hj Mazlan Hj Bin Ahmad

Chief Executive Officer
QMIS TBS Capital Group Corp.
Effective
2024-06-24
Filed
June 25, 2024, 7:59 PM ET
the Company’s Board of Directors had appointed Dr Hj Mazlan Hj Bin Ahmad to serve as the Company’s Chief Executive Officer, effective immediately.
Role change

Dr. Chin Yung Kong

Chief Executive Officer
QMIS TBS Capital Group Corp.
Effective
2024-06-24
Successor
Dr. Hj Mazlan Hj Bin Ahmad
Filed
June 25, 2024, 7:59 PM ET
Dr. Chin Yung Kong, one of the founders and a long-time officer of the Company, had chosen to resign as Chief Executive Officer of the Company, effective immediately.
Departed

Christopher S. Sotos

President and Chief Executive Officer
CWEN · Clearway Energy, Inc.
Effective
2024-06-30
Filed
June 25, 2024, 7:59 PM ET
Christopher S. Sotos informed Clearway Energy, Inc. (the “Company”) on April 30, 2024 that, effective as of June 30, 2024, he will move on from his position as President and Chief Executive Officer of the Company and resign from his role as a member of the Board of Directors (the “Board”) of the Company.
Departed

Justin Earl

Chief Executive Officer
BHIC · BioScience Health Innovations, Inc.
Successor
Darren Lopez
Filed
June 25, 2024, 7:59 PM ET
Justin Earl tendered his resignation as the sole officer of the Company.
Appointed

Darren Lopez

Chief Executive Officer
BHIC · BioScience Health Innovations, Inc.
Filed
June 25, 2024, 7:59 PM ET
Darren López was appointed as the Chief Executive Officer of the Company.
Appointed

William A. Byers

Chief Financial Officer
TRGP · Targa Resources Corp.
Effective
2024-07-22
Filed
June 25, 2024, 7:59 PM ET
the Board also appointed William A. Byers to serve as the Company’s Chief Financial Officer, effective as of July 22, 2024.
Departed

Daniel Jones

President, Chief Executive Officer and Chairman
ATLN · ATLANTIC INTERNATIONAL CORP.
Filed
June 25, 2024, 7:59 PM ET
the following officers resigned: Daniel Jones, President, Chief Executive Officer and Chairman
Departed

Francis Scully

Chief Financial Officer and Security
ATLN · ATLANTIC INTERNATIONAL CORP.
Filed
June 25, 2024, 7:59 PM ET
the following officers resigned: Daniel Jones, President, Chief Executive Officer and Chairman, and Francis Scully, Chief Financial Officer and Security
Appointed

Andrew M. Johnson

Chief Financial Officer
ASTS · AST SpaceMobile, Inc.
Effective
2024-06-19
Filed
June 25, 2024, 7:59 PM ET
Andrew M. Johnson as Chief Financial Officer
Departed

Sean Wallace

Chief Financial Officer
ASTS · AST SpaceMobile, Inc.
Effective
2024-07-12
Successor
Andrew M. Johnson
Filed
June 25, 2024, 7:59 PM ET
Sean Wallace, who served as Chief Financial Officer until Mr. Johnson’s appointment, will leave employment with the Company effective July 12, 2024.
Role change

Matthew Lesmeister

Chief Financial Officer
FLYX · FLYEXCLUSIVE INC.
Effective
2024-06-25
Filed
June 25, 2024, 7:59 PM ET
the Company appointed Matthew Lesmeister as Chief Financial Officer
Departed

Billy Barnard

Interim Chief Financial Officer
FLYX · FLYEXCLUSIVE INC.
Effective
2024-06-18
Successor
Matthew Lesmeister
Filed
June 25, 2024, 7:59 PM ET
On June 18, 2024, Billy Barnard, the Interim Chief Financial Officer of flyExclusive, Inc. (the “Company”), resigned, effective immediately.
Departed

Brianna Gerber

Chief Financial Officer and Chief Accounting Officer
NAGE · Niagen Bioscience, Inc.
Effective
2024-07-12
Filed
June 25, 2024, 7:59 PM ET
On June 19, 2024, Brianna Gerber, the Chief Financial Officer and Chief Accounting Officer of ChromaDex Corporation (the “Company”), informed the Company that she will be resigning from her roles with the Company, effective July 12, 2024 (the “Separation Date”).
Appointed

Jennifer L. Slater

President and Chief Executive Officer
STRT · STRATTEC SECURITY CORP
Effective
2024-07-01
Filed
June 24, 2024, 7:59 PM ET
Effective July 1, 2024, Mr. Guillot will return to his role as Senior Vice President – Operations and Chief Operating Officer upon the appointment of Jennifer L. Slater as President and Chief Executive Officer, as previously disclosed by the Company in its Current Report on Form 8-K filed on June 14, 2024.
Departed

Michael Byrnes

Chief Financial Officer and Secretary
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, Stephen T. Worland, Ph.D., President and CEO, Michael Byrnes, Chief Financial Officer and Secretary, and Douglas Warner, M.D., Chief Medical Officer, ceased serving in their respective officer positions.
Appointed

Craig R. Jalbert

CEO, President, Treasurer and Secretary
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, the Board appointed Craig R. Jalbert, age 62, as the Company’s CEO, President, Treasurer and Secretary, and sole member of the Board.
Departed

Stephen T. Worland, Ph.D.

President and CEO
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, Stephen T. Worland, Ph.D., President and CEO, Michael Byrnes, Chief Financial Officer and Secretary, and Douglas Warner, M.D., Chief Medical Officer, ceased serving in their respective officer positions.
Appointed

John M. McCaffery

Executive Vice President and Chief Financial Officer
NWFL · NORWOOD FINANCIAL CORP
Effective
2024-06-24
Filed
June 24, 2024, 7:59 PM ET
the Board of Directors had appointed John M. McCaffery as Executive Vice President and Chief Financial Officer of the Company, and its wholly owned subsidiary, Wayne Bank (the “Bank”), effective as of June 24, 2024.
Departed

Alexander J. Bruni

Executive Vice President & Chief Financial Officer
ACH · ACCENDRA HEALTH INC/VA/
Effective
2024-06-21
Successor
Jonathan A. Leon
Filed
June 24, 2024, 7:59 PM ET
Alexander J. Bruni, the Company’s Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.
Appointed (interim)

Jonathan A. Leon

Interim Chief Financial Officer
ACH · ACCENDRA HEALTH INC/VA/
Effective
2024-06-21
Filed
June 24, 2024, 7:59 PM ET
Jonathan A. Leon, the Company’s Senior Vice President, Corporate Treasurer, has been appointed as interim Chief Financial Officer effective June 21, 2024.
Appointed

Robert Ragusa

Chief Executive Officer
GRAL · GRAIL, Inc.
Effective
2024-06-21
Filed
June 24, 2024, 7:59 PM ET
Robert Ragusa Chief Executive Officer
Appointed

Aaron Freidin

Chief Financial Officer
GRAL · GRAIL, Inc.
Effective
2024-06-21
Filed
June 24, 2024, 7:59 PM ET
Aaron Freidin Chief Financial Officer
Appointed

Christopher H. Bohnert

Senior Vice President, Chief Financial Officer
NNBR · NN INC
Effective
2024-06-25
Filed
June 24, 2024, 7:59 PM ET
the Board also announced that Christopher H. Bohnert has been appointed to fill the newly-created vacancy of Senior Vice President, Chief Financial Officer, effective as of the Transition Date.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.